课题基金 / 基金详情

PROSTAVASIN AND SEVERE PERIPHERAL ARTERIAL OCCLUSIVE DISEASE

PROSTAVASIN AND SEVERE PERIPHERAL ARTERIAL OCCLUSIVE DISEASE
前列腺素和严重外周动脉闭塞性疾病
批准号：
3850310
负责人：
JOHN M. PORTER
金额：
$0.0万
依托单位：
OREGON HEALTH & SCIENCE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3850310
关键词：
cardiovascular disorder chemotherapy clinical trials drug administration rate /duration human subject human therapy evaluation intravenous administration ischemia peripheral blood vessel disorder prostaglandin E ulcer

项目摘要

项目成果

JOHN M. PORTER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This study is a randomized, double-blind, multicenter, placebo-controlled, parallel group trial to evaluate the safety and efficacy of daily intravenous infusions of Prostavasin (PGE1) or placebo over 28 consecutive days in patients with severe peripheral arterial occlusive disease and ischemic ulcers, who are not operative candidates.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CHRONIC ADMINISTRATION OF CILOSTAZOL IN PATIENTS WITH INTERMITTENT CLAUDICATION
DIAGNOSIS, PATHOPHYSIOLOGY AND CLINICAL COURSE OF RAYNAUD'S SYNDROME
NATURAL HISTORY OF RAYNAUD'S SYNDROME
NATURAL HISTORY OF RAYNAUD'S SYNDROME
海外基金